Results 11 to 20 of about 37,916 (265)

Quinazolinone-Amino Acid Hybrids as Dual Inhibitors of EGFR Kinase and Tubulin Polymerization [PDF]

open access: yesMolecules, 2018
Some fluoroquinazolinones (A–H) were designed, synthesized and biologically evaluated for their antitumor activity against the two cell lines, MCF-7 and MDA-MBA-231.
Mohamed F. Zayed   +4 more
doaj   +2 more sources

Comparative Analysis of 3D Bladder Tumor Spheroids Obtained by Forced Floating and Hanging Drop Methods for Drug Screening [PDF]

open access: yesFrontiers in Physiology, 2017
Introduction: Cell-based assays using three-dimensional (3D) cell cultures may reflect the antitumor activity of compounds more accurately, since these models reproduce the tumor microenvironment better.Methods: Here, we report a comparative analysis of ...
Robson L. F. Amaral   +3 more
doaj   +3 more sources

Repurposing the Antibacterial Activity of the Drug Teniposide Against Gram-Positive Bacteria [PDF]

open access: yesCellular Microbiology
Drug repurposing is sparking considerable interest due to reduced costs and development times. The current study details the screening of teniposide, an antitumor drug, for its antibacterial activity against both Gram-positive and Gram-negative strains ...
Federica Dell’Annunziata   +9 more
doaj   +4 more sources

In vitro antitumor activity of methotrexate via pH-sensitive chitosan nanoparticles [PDF]

open access: yes, 2013
Nanoparticles with pH-sensitive behavior may enhance the success of chemotherapy in many cancers by efficient intracellular drug delivery. Here, we investigated the effect of a bioactive surfactant with pH-sensitive properties on the antitumor activity ...
Vinardell, M. Pilar   +10 more
core   +1 more source

High throughput screens yield small molecule inhibitors of Leishmania CRK3:CYC6 cyclin-dependent kinase [PDF]

open access: yes, 2011
<p><b>Background:</b> <i>Leishmania</i> species are parasitic protozoa that have a tightly controlled cell cycle, regulated by cyclin-dependent kinases (CDKs).
Mottram Jeremy C.   +59 more
core   +1 more source

Discovery of a Novel Potent Antitumor Molecule, P19G1, by Erlotinib Derivative Libraries Synthesized by Modular Click-Chemistry

open access: yesTechnology in Cancer Research & Treatment, 2022
Objective: Traditional chemical synthesis methods are cumbersome and inefficient. In this study, a novel antitumor molecule, 4-(4-(3-((6,7-bis(2-methoxyethoxy)quinazolin-4-yl)amino)phenyl)-1H-1,2,3-triazol-1-yl)phenyl sulfurofluoridate (P19G1), was ...
Qianfei Cui PhD   +9 more
doaj   +1 more source

DataSheet1_Synthesis and Discovery of Ligustrazine–Heterocycle Derivatives as Antitumor Agents.docx [PDF]

open access: yes, 2022
Ligustrazine (TMP) is a natural pyrazine alkaloid extracted from the roots of Ligusticum Chuanxiong Hort, which has the potential as an antitumor agent.
Ning Zhang (23771)   +9 more
core   +1 more source

A rapid primary screening method for antitumor using the oomycete Pythium aphanidermatum. [PDF]

open access: yes, 2018
Investigating bioactive components from microbial metabolites can provide potential source for drug discovery. There are a number of traditional antitumor compounds screening assays already described.
MELO, I. S. de, SANTOS, S. N.
core   +1 more source

Lomerizine 2HCl inhibits cell proliferation and induces protective autophagy in colorectal cancer via the PI3K/Akt/mTOR signaling pathway

open access: yesMedComm, 2021
Colorectal cancer (CRC) is one of the most common malignancies currently. Despite advances in drug development, the survival and response rates in CRC patients are still poor.
Xiang‐Peng Tan   +8 more
doaj   +1 more source

Radiosensitization in esophageal squamous cell carcinoma Effect of polo-like kinase 1 inhibition [PDF]

open access: yes, 2017
Purpose This study examined the efficacy of polo-like kinase 1 (PLK1) inhibition on radiosensitivity in vitro and in vivo by a pharmacologic approach using the highly potent PLK1 inhibitor volasertib.
Chen, Jenny Ling-Yu;Chen, Jo-Pai;Huang, Yu-Sen;Tsai, Yuan-Chun;Tsai, Ming-Hsien;Jaw, Fu-Shan;Cheng, Jason Chia-Hsien;Kuo, Sung-Hsin;Shieh, Ming-Jium   +1 more
core   +1 more source

Home - About - Disclaimer - Privacy